Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Acute Stroke
Interventions
BIOLOGICAL

UMSC01

There will be one dose of IV administration in patients with acute ischemic stroke, or one dose of IV administration followed by low or high doses of IA infusion for acute ischemic stroke with or without bridging therapy (i.e. Intravenous rt-PA thrombolysis or intraarterial thrombectomy) with 12 months of follow up after the first treatment.

Trial Locations (1)

404

China Medical University Hospital, Taichung

All Listed Sponsors
lead

Ever Supreme Bio Technology Co., Ltd.

INDUSTRY